{"id":"https://openalex.org/W2584428874","doi":"https://doi.org/10.2174/1381612823666170125154257","title":"The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins","display_name":"The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins","publication_year":2017,"publication_date":"2017-02-23","ids":{"openalex":"https://openalex.org/W2584428874","doi":"https://doi.org/10.2174/1381612823666170125154257","mag":"2584428874","pmid":"https://pubmed.ncbi.nlm.nih.gov/28128061"},"language":"en","primary_location":{"id":"doi:10.2174/1381612823666170125154257","doi":"https://doi.org/10.2174/1381612823666170125154257","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612823666170125154257","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091008679","display_name":"Vasilios Gabriel Athyros","orcid":"https://orcid.org/0000-0002-0882-8676","observed_orcids":["https://orcid.org/0000-0002-0882-8676"]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]},{"id":"https://openalex.org/I4210116665","display_name":"Ippokrateio General Hospital of Thessaloniki","ror":"https://ror.org/02kpyrm37","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210116665"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"Vasilios G. Athyros","raw_affiliation_strings":["Head of Metabolic Disease Units, 2nd Pop. Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocrates Hospital, Thessaloniki, Greece. 15 Marmara St, Thessaloniki, 55132, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head of Metabolic Disease Units, 2nd Pop. Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocrates Hospital, Thessaloniki, Greece. 15 Marmara St, Thessaloniki, 55132, Greece","institution_ids":["https://openalex.org/I21370196","https://openalex.org/I4210116665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076157401","display_name":"\u039a\u03c9\u03bd\u03c3\u03c4\u03b1\u03bd\u03c4\u03af\u03bd\u03bf\u03c2 \u03a4\u03b6\u03b9\u03cc\u03bc\u03b1\u03bb\u03bf\u03c2","orcid":"https://orcid.org/0000-0002-3172-1594","observed_orcids":["https://orcid.org/0000-0002-3172-1594"]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]},{"id":"https://openalex.org/I2800980381","display_name":"AHEPA University Hospital","ror":"https://ror.org/01q1jaw52","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I2800980381"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Konstantinos Tziomalos","raw_affiliation_strings":["First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196","https://openalex.org/I2800980381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079707370","display_name":"Michael N. Doumas","orcid":"https://orcid.org/0000-0002-7269-8044","observed_orcids":["https://orcid.org/0000-0002-7269-8044"]},"institutions":[{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]},{"id":"https://openalex.org/I4210154891","display_name":"Washington DC VA Medical Center","ror":"https://ror.org/050fz5z96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210111569","https://openalex.org/I4210154891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Doumas","raw_affiliation_strings":["Department of Veterans Affairs and George Washington University, VA Medical Centre, 50 Irving Street, NW-151-E, Washington, DC 20422, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Veterans Affairs and George Washington University, VA Medical Centre, 50 Irving Street, NW-151-E, Washington, DC 20422, United States","institution_ids":["https://openalex.org/I1322918889","https://openalex.org/I193531525","https://openalex.org/I4210154891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010483333","display_name":"George Sfikas","orcid":"https://orcid.org/0000-0001-6260-7658","observed_orcids":["https://orcid.org/0000-0001-6260-7658"]},"institutions":[{"id":"https://openalex.org/I4210119702","display_name":"424 General Military Hospital","ror":"https://ror.org/02cpzy455","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210119702"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"George Sfikas","raw_affiliation_strings":["424 Military Hospital of Thessaloniki, Thessaloniki, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"424 Military Hospital of Thessaloniki, Thessaloniki, Greece","institution_ids":["https://openalex.org/I4210119702"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068639798","display_name":"Asterios I. Karagiannis","orcid":"https://orcid.org/0000-0003-1517-6984","observed_orcids":["https://orcid.org/0000-0003-1517-6984"]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]},{"id":"https://openalex.org/I4210116665","display_name":"Ippokrateio General Hospital of Thessaloniki","ror":"https://ror.org/02kpyrm37","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210116665"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Asterios Karagiannis","raw_affiliation_strings":["Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196","https://openalex.org/I4210116665"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5091008679"],"corresponding_institution_ids":["https://openalex.org/I21370196","https://openalex.org/I4210116665"],"apc_list":null,"apc_paid":null,"fwci":1.2488,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.80389052,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"23","issue":"10","first_page":"1477","last_page":"1483"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pcsk9","display_name":"PCSK9","score":0.9670000076293945},{"id":"https://openalex.org/keywords/glucose-metabolism","display_name":"glucose metabolism","score":0.8270000219345093},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9810000061988831},{"id":"https://openalex.org/keywords/new-onset-diabetes","display_name":"new-onset diabetes","score":0.777999997138977},{"id":"https://openalex.org/keywords/statin-adverse-effects","display_name":"statin adverse effects","score":0.7350000143051147},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.6240000128746033},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9110000133514404},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8339999914169312},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.8040000200271606},{"id":"https://openalex.org/keywords/anti-pcsk9-monoclonal-antibodies","display_name":"anti-PCSK9 monoclonal antibodies","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.8470112085342407},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.7840931415557861},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.719641923904419},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.7026137113571167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6641623973846436},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6185779571533203},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6109321117401123},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5366738438606262},{"id":"https://openalex.org/C17093226","wikidata":"https://www.wikidata.org/wiki/Q2734081","display_name":"Carbohydrate metabolism","level":2,"score":0.48947250843048096},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.48909980058670044},{"id":"https://openalex.org/C2779811187","wikidata":"https://www.wikidata.org/wiki/Q423655","display_name":"Subtilisin","level":3,"score":0.48495057225227356},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3769778609275818},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34200066328048706},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.31002771854400635},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.23688825964927673},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1279447376728058},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.10505151748657227},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10463541746139526}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1381612823666170125154257","doi":"https://doi.org/10.2174/1381612823666170125154257","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612823666170125154257","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:28128061","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28128061","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4380360249","https://openalex.org/W2940133596","https://openalex.org/W4394764488","https://openalex.org/W4214885613","https://openalex.org/W2902436102","https://openalex.org/W2560403714","https://openalex.org/W3134210343","https://openalex.org/W2733425720","https://openalex.org/W2578413769","https://openalex.org/W2923483251"],"abstract_inverted_index":{"BACKGROUND:":[0],"Statins":[1],"remain":[2],"the":[3,59,75,82,86,117,217,232],"cornerstone":[4],"of":[5,26,50,77,148,197,219,234],"hypolipidaemic":[6],"drug":[7],"treatment.":[8],"However,":[9],"statins":[10],"exert":[11],"adverse":[12],"effects":[13],"on":[14,85],"glucose":[15,27,109,121,212],"metabolism.":[16],"Given":[17],"that":[18,97,174],"new":[19],"onset":[20],"diabetes":[21,35],"mellitus":[22,36],"(NODM)":[23],"and":[24,91,113,122,150,170,214],"worsening":[25],"control":[28],"in":[29,136,143,151,164,181,190],"patients":[30,137,144,152,165,182],"with":[31,131,153,166,183],"established":[32,154],"type":[33,65],"2":[34],"(T2DM)":[37],"is":[38,57],"related":[39,106,203],"to":[40,53,107,201,204,226],"low":[41,139],"density":[42],"lipoprotein":[43],"cholesterol":[44],"(LDL-C)":[45],"reduction,":[46],"it":[47],"would":[48],"be":[49,72,202],"great":[51],"interest":[52],"investigate":[54],"if":[55],"this":[56],"also":[58],"case":[60],"for":[61,74,141],"proprotein":[62],"convertase":[63],"subtilisin-kexin":[64],"9":[66],"(PCSK9)":[67],"inhibitors,":[68],"which":[69],"have":[70,225],"recently":[71],"licensed":[73],"treatment":[76,130],"hypercholesterolaemia.":[78],"METHODS:":[79],"We":[80],"reviewed":[81],"published":[83],"papers":[84],"relation":[87],"between":[88],"circulating":[89,99],"PCSK9":[90,100,135,175,198],"diabetogenesis.":[92],"RESULTS:":[93],"Recent":[94],"data":[95,172],"suggest":[96,173],"increased":[98,108],"levels,":[101,110],"besides":[102],"causing":[103],"dyslipidaemia,":[104],"are":[105,125,161],"metabolic":[111],"syndrome,":[112],"even":[114],"T2DM.":[115,155,193],"On":[116],"contrary,":[118],"fasting":[119],"plasma":[120],"HbA1c":[123],"levels":[124],"not":[126],"adversely":[127,210],"affected":[128,163],"during":[129],"human":[132],"antibodies":[133],"against":[134],"at":[138,145,185],"risk":[140,147],"T2DM,":[142,169],"high":[146],"T2DM":[149,184],"Plasma":[156],"lipoproteins":[157],"(mainly":[158],"LDL-C":[159],"reduction)":[160],"similarly":[162],"or":[167],"without":[168,192,209,215],"recent":[171],"inhibition":[176],"might":[177],"reduce":[178],"cardiovascular":[179],"events":[180],"least":[186],"as":[187,189],"much":[188],"those":[191],"CONCLUSION:":[194],"The":[195],"use":[196,233],"inhibitors":[199],"appears":[200],"a":[205],"substantial":[206],"clinical":[207],"benefit":[208],"affecting":[211],"metabolism":[213],"increasing":[216],"incidence":[218],"NODM.":[220],"Large":[221],"ongoing":[222],"studies":[223],"will":[224],"confirm":[227],"these":[228,235],"findings":[229],"before":[230],"expanding":[231],"agents.":[236]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-02-10T00:00:00"}